EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

 ISSN (O) : 2394-3211

 ISSN (P) : 3051-2573

Impact Factor: 8.158

 ICV - 79.57

Abstract

ANTIBIOTIC RESTRICTION POLICIES: A COMPARATIVE STUDY OF IMPLEMENTATION AND OUTCOMES AT PRINCE ZAID BIN AL-HUSSEIN MILITARY HOSPITAL AND PRINCE ALI BIN AL-HUSSEIN MILITARY HOSPITAL

Dr. Amjad A. G. Alhawamdeh*, Dr. Ma’moon K. H. A. AL-Khawaldeh, Dr. Rashid A. S. Alharahsheh, Dr. Ma’moon M. A. El- Harahshah, Dr. Hossam E. S. Alsmairan, Mohammad E. M. Albdairat Pharm-D, Rami Mahmoud Ali AL-Lawama P. H.

ABSTRACT

Introduction: A major threat to global health, antimicrobial resistance (AMR) raises hospital stays, costs, and
mortality rates, Applying restrictive antimicrobials policies in hospitals, where certain high-risk antibiotics need
special authorization before usage, stays an important strategy to fight AMR. Although many Jordanian hospitals
have implemented such rules, the majority of research to far has concentrated on individual hospitals rather than
comparing practices across hospitals, these results in a lack of knowledge regarding the actual implementation of
policies and their efficacy in various contexts. In order to close that gap, this study compares the antibiotic
restriction policies of Prince Zaid bin Al-Hussein military Hospital and Prince Ali bin Al-Hussein military
Hospital, two of Jordan's large military hospitals. Methodology: The essential method involves a comparative
analysis of restricted antibiotic use between the two military hospitals, Data on the total consumption of targeted
antibiotics and the corresponding total patient-days (calculated from admissions and bed occupancy) will be
collected then This will allow for the calculation and comparison of a standardized consumption rate (using the
metric DDD/100 patient-days) for each institution, In parallel, the total acquisition cost for these drugs will be
compiled and compared, The analysis will then integrate these findings, examining the relationship between
consumption rate and financial cost to provide a clear, brief evaluation of both usage patterns and economic
outcomes. Results: Imipenem/Cilastatin (1 g) was the most dispensed restricted antibiotic in both hospitals, Ali
Hospital had higher annual bed occupancy 49,802 bed-days compared to Zaid Hospital 14,601 bed-days, After
standardizing consumption, the rates of antibiotic use per 100 bed-days were similar between the two hospitals.
The financial analysis revealed the cost per DDD is identical for each antibiotic in both hospitals, but
Imipenem/Cilastatin representing the highest cost driver, Zaid Hospital established higher costs per 100 bed-days
for all antibiotics. Conclusion: Although Ali Hospital dispensed a higher number of restricted antibiotic vials, the
adjusted consumption rates and associated costs per 100 bed-days were very similar between Ali and Zaid
hospitals. Imipenem/cilastatin was the most frequently used restricted antibiotic and the major contributor to
financial burden in both institutions; these findings indicate comparable prescribing patterns.

Keywords: Antibiotics, restricted antibiotics, antimicrobials, cost.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

LOGIN333

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 April 2026 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: APRIL ISSUE PUBLISHED

    APRIL 2026 issue has been successfully launched on APRIL 2026.

  • EJPMR: New Impact Factor 2026

    EJPMR Impact Factor has been Increased from 7.065 to 8.158, for Year 2026

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here